By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited (BUGDF)

OTC Market Data in USD, Fundamentals in THB
$4.23
$0.00
0.00%
Last Update: 29 Aug 2025, 00:00
$3.36B
Market Cap
15.93
P/E Ratio (TTM)
2.91%
Forward Dividend Yield
$3.95 - $7.91
52 Week Range

BUGDF Stock Price Chart

Explore Bumrungrad Hospital Public Company Limited interactive price chart. Choose custom timeframes to analyze BUGDF price movements and trends.

BUGDF Company Profile

Discover essential business fundamentals and corporate details for Bumrungrad Hospital Public Company Limited (BUGDF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

5 Apr 2010

Employees

CEO

Artirat Charukitpipat

Description

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.

BUGDF Financial Timeline

Browse a chronological timeline of Bumrungrad Hospital Public Company Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 22 Apr 2026

Upcoming earnings on 25 Feb 2026

Upcoming earnings on 6 Nov 2025

Dividend declared on 30 Jul 2025

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 1 Sept 2025.

Earnings released on 29 Jul 2025

EPS came in at $2.14 surpassing the estimated $0.06 by +3.22K%, while revenue for the quarter reached $6.02B , missing expectations by -8.88%.

Earnings released on 24 Apr 2025

EPS came in at $2.00 surpassing the estimated $0.06 by +3.04K%, while revenue for the quarter reached $6.14B , missing expectations by -7.21%.

Dividend declared on 26 Feb 2025

A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 15 May 2025.

Earnings released on 25 Feb 2025

EPS came in at $2.19 surpassing the estimated $0.06 by +3.35K%, while revenue for the quarter reached $6.47B , beating expectations by +1.41%.

Earnings released on 7 Nov 2024

EPS came in at $2.25 surpassing the estimated $0.08 by +2.82K%, while revenue for the quarter reached $6.41B , beating expectations by +2.81K%.

Earnings released on 8 Aug 2024

EPS came in at $2.23 surpassing the estimated $0.06 by +3.58K%, while revenue for the quarter reached $6.28B , beating expectations by +3.38K%.

Dividend declared on 8 Aug 2024

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 9 Sept 2024.

Earnings released on 25 Apr 2024

EPS came in at $2.29 surpassing the estimated $0.06 by +3.73K%, while revenue for the quarter reached $6.52B , beating expectations by +3.63K%.

Earnings released on 22 Feb 2024

EPS came in at $1.98 surpassing the estimated $0.06 by +3.19K%, while revenue for the quarter reached $6.50B , beating expectations by +3.32K%.

Dividend declared on 21 Feb 2024

A dividend of $0.09 per share was announced, adjusted to $0.09. The dividend was paid on 15 May 2024.

Earnings released on 30 Sept 2023

EPS came in at $2.25 surpassing the estimated $0.06 by +3.42K%, while revenue for the quarter reached $6.74B , beating expectations by +3.48K%.

Dividend declared on 9 Aug 2023

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 7 Sept 2023.

Earnings released on 30 Jun 2023

EPS came in at $2.01 surpassing the estimated $0.05 by +4.01K%, while revenue for the quarter reached $6.05B , beating expectations by +3.69K%.

Earnings released on 31 Mar 2023

EPS came in at $1.83 surpassing the estimated $0.05 by +3.64K%, while revenue for the quarter reached $6.05B , beating expectations by +3.57K%.

Dividend declared on 15 Feb 2023

A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 May 2023.

Earnings released on 31 Dec 2022

EPS came in at $1.78 surpassing the estimated $0.05 by +3.62K%, while revenue for the quarter reached $5.99B , beating expectations by +3.69K%.

Earnings released on 30 Sept 2022

EPS came in at $1.73 surpassing the estimated $0.04 by +4.73K%, while revenue for the quarter reached $5.69B , beating expectations by +4.18K%.

Dividend declared on 10 Aug 2022

A dividend of $0.03 per share was announced, adjusted to $0.03. The dividend was paid on 9 Sept 2022.

Earnings released on 30 Jun 2022

EPS came in at $1.34 surpassing the estimated $0.03 by +5.22K%, while revenue for the quarter reached $4.92B , beating expectations by +4.01K%.

Earnings released on 31 Mar 2022

EPS came in at $0.84 surpassing the estimated $0.02 by +4.25K%, while revenue for the quarter reached $4.12B , beating expectations by +3.77K%.

Dividend declared on 11 Mar 2022

A dividend of $0.06 per share was announced, adjusted to $0.06. The dividend was paid on 10 May 2022.

Earnings released on 31 Dec 2021

EPS came in at $0.71 , while revenue for the quarter reached $3.90B .

Earnings released on 30 Sept 2021

EPS came in at $0.34 surpassing the estimated $0.01 by +2.79K%, while revenue for the quarter reached $2.91B , beating expectations by +2.87K%.

Dividend declared on 13 Aug 2021

A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 9 Sept 2021.

Earnings released on 30 Jun 2021

EPS came in at $0.25 , while revenue for the quarter reached $2.99B .

Earnings released on 31 Mar 2021

EPS came in at $0.11 , while revenue for the quarter reached $2.66B .

Dividend declared on 17 Feb 2021

A dividend of $0.07 per share was announced, adjusted to $0.07. The dividend was paid on 12 May 2021.

Earnings released on 31 Dec 2020

EPS came in at $0.20 , while revenue for the quarter reached $2.93B .

Earnings released on 30 Sept 2020

EPS came in at $0.26 , while revenue for the quarter reached $2.90B .

BUGDF Stock Performance

Access detailed BUGDF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run